Startup Atavistik Adds $40M for Clinical Trial in Rare Bleeding Disorder With No Approved Therapies – MedCity News
Atavistik Bio has raised an additional $40 million as the startup prepares for clinical testing of a drug in development…
Atavistik Bio has raised an additional $40 million as the startup prepares for clinical testing of a drug in development…